DOI:
10.1055/s-00000077
Seminars in Thrombosis and Hemostasis
LinksClose Window
References
Mueck W, Borris LC, Dahl OE , et al.
Population pharmacokinetics and pharmacodynamics of once- and twice-daily rivaroxaban for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Thromb Haemost 2008;
100 (3) 453-461
Access:
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.